Latvia vs Libya: Estimated antiretroviral therapy coverage among people living with HIV
Latvia
52.0%
in 2024
Libya
53.0%
in 2025
Latvia rank
122nd
Libya rank
120th
Estimated antiretroviral therapy coverage among people living with HIV over time
- Latvia
- Libya
How they compare
Libya currently reports 53.0% against 52.0% in Latvia, a difference of 1.0%.
The two have swapped places 2 times across 24 shared years of data; in 2000 it was Libya ahead.
Latvia ranks 122nd and Libya ranks 120th of 143 countries.
Libya has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Latvia | Libya | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 3.1% | 22.4% | 19.3% | Libya |
| 2010s | 22.0% | 55.9% | 33.9% | Libya |
| 2020s | 49.2% | 49.5% | 0.2% | Libya |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher estimated antiretroviral therapy coverage among people living with hiv, Latvia or Libya?
- Libya, at 53.0% against 52.0% in Latvia as of 2025.
- What is the difference in estimated antiretroviral therapy coverage among people living with hiv between Latvia and Libya?
- 1.0%, with Libya ahead.
- How many years of comparable data are there for Latvia and Libya?
- 24 years are reported by both, from 2000 to 2023.
- How do Latvia and Libya rank globally for estimated antiretroviral therapy coverage among people living with hiv?
- Latvia ranks 122nd and Libya ranks 120th of 143 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Estimated antiretroviral therapy coverage among people living with HIV (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.